Hjem › Kronisk myeloid leukæmi › Alabama
Kronisk myeloid leukæmi kliniske forsøg i Alabama
6 studier for Kronisk myeloid leukæmi søger deltagere på steder i Alabama.
Byer i Alabama
Officiel studietekst (engelsk)
Study of Olverembatinib (HQP1351) in Patients With CML-CP
- Ascentage Investigative Site #1044, Birmingham
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT06423911A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- University of Alabama at Birmingham, Birmingham
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 6. jul. 2026 · NCT01351545A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
- University of Alabama Birmingham, Birmingham
RekruttererFase 2
Alder 18 til 66 · Alle køn · Opdateret 17. mar. 2026 · NCT06859424A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)
- University of Alabama Medicine (UAB Medicine), Birmingham
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 12. jan. 2026 · NCT06163430Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
- University of Alabama at Birmingham, Birmingham
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 5. nov. 2025 · NCT04260022HPC Offered for PRESERVE Expansion
- University of Alabama, Birmingham, Birmingham
RekruttererObservationsstudie
Alder 12 til 80 · Alle køn · Opdateret 28. aug. 2025 · NCT07145411Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.